Author Guidelines

INSTRUCTIONS TO AUTHORS

SCOPE & AIM

E-Da Medical Journal (E-Da Med J) is a peer-reviewed open access journal that is published quarterly in March, June, September, and December. The journal invites original contributions related to all fields of medicine and relevant disciplines that are of interest to the medical profession around the world.

SUBMISSION & REVIEW PROCESS

All manuscripts to be submitted must be original and have not been previously published in or submitted for publication to any other journal. All articles should be written in English and submitted online through the iPress website (https://www.ipress.tw/J0181). Along with each submission, a declaration stating that all of the authors agree on the contents of the article should be added. Please use the E-Da Med J Transfer of Copyright Agreement form. The signatures of all authors must be included. A message of successful submission will be sent to the corresponding author through an email.

EDITORIAL REVIEW AND ACCEPTANCE

All articles are reviewed by two or more referees. E-Da Med J adopts a double-blind peer review process in which the authors’ identities are concealed from the reviewers and vice versa. If an article is accepted for publication, editorial revision may be made to aid clarity. The copyright of accepted articles belongs to the E-Da Med Journal and cannot be transferred without written permission.

POLICIES ON CONFLICTS OT INTEREST, HUMAN AND ANIMAL RIGHTS, AND INFORMED CONSENT

E-Da Med J requires authors to declare all competing interests in relation to their work. All submitted manuscripts must include a Conflicts of Interest Statement at the end of the manuscript listing all competing interests (financial and non-financial). Where authors have no competing interests, the statement should read “The authors have declared no competing interests related to this work.” Editors may ask for further information pertinent to competing interests. Editors and reviewers are also required to declare any competing interests and will be excluded from the peer review process if a competing interest exists.

All manuscripts involving human subjects, human materials, or human data must have been conducted in compliance with the Declaration of Helsinki and must include a statement in the methods section identifying the institutional and/or licensing committee approving the protocol and procedures, including the registration number of the approval certificate as well as any relevant details regarding patient anonymity, drug side-effects, and informed consent if applicable. All participants should have signed an informed consent unless the related ethical review committee deemed it otherwise.

All manuscripts involving animal experimentation must contain a statement in the methods section detailing the committee reviewing and approving the study including the registration number of the approved certificate.

MANUSCRIPT TYPES

Original Article (Including Meta-Analysis)

Abstract. Following the title page, the second page should include an abstract of not more than 250 words. The abstract should be structured and contain the following sections:

Objective(s): describe the hypothesis or the purpose of the study.
Methods: identify the study design and statistical methods used.
Results: describe the outcome of the study and the statistical significance, if appropriate.
Conclusion(s): state the significance of the results.

Text. The text should begin on the third page and for most original articles should include the following sections: Introduction, Materials and Methods, Results, Discussion, Conflicts of Interest Statement, Acknowledgments (if any), and References. For a meta-analysis, the subtitle should include “A Meta-Analysis” and the text should clearly indicate a full compliance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Reporting Guidelines or MOOSE (Meta-Analysis of Observational Studies in Epidemiology) Reporting Guidelines. A PRISMA checklist should be attached as a supplementary file on submission and a PRISMA flowchart should be included as a figure of the manuscript. The total number of references should not be more than 30 for an original article, and 100 for a meta-analysis.

Case Reports

For case reports, a non-structured abstract not more than 250 words is needed. The abstract should include statements of the problem and clinical manifestations as well as methods of treatment and outcome. The “Materials and Methods” and “Results” sections in the main text should be replaced by the Case Report(s) section. This section should include statements of the problem, patient history, diagnosis, treatment, results, and any other information pertinent to the case(s). All other sections should follow the format for original articles. The number of co-authors should be no more than six and the total number of references should not be more than 10.

Images

These include radiographs, photographs of pathology, images taken in the operating room, or other relevant clinical pictures of unusual findings of diseases, typical features of uncommon diseases, and rare presentations or findings of common medical or surgical problems. The images with relevant history, clinical and laboratory findings, details of (any) surgical intervention and outcomes should tell the story. Descriptions of images must be included in the text. Removal of all information that could identify patients before submitting images is required. The number of references should be no more than five.

Brief Communications

All invited manuscripts submitted as Brief Communications should be concise and contain short clinical or technical notes, or preliminary experimental results. They should not exceed a total of three printed pages and not include more than three illustrations. The abstract for a Brief Communication should be non-structured and not exceed 250 words. The number of references should be no more than five.

Letters to the Editor

Letters are welcome in response to articles previously published in this journal. They should be submitted within two months of publication of the article and should be no more than 500 words, and they may include two tables or figures and up to five references. The editorial board reserves the right to edit any letter received.

Invited Review Article

All review articles are commissioned by the Editor.

GENERAL FORMAT

Preparation of Manuscript

The format of manuscripts for this Journal must comply with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (URMs), current URMs are available at http://www.icmje.org. All units of measurement and laboratory values must be expressed in SI units and symbols. Abbreviations should be kept to an absolute minimum. Uncommon abbreviations should be defined in the text when first mentioned. If first mentioned in the abstract, they must be defined again in the main text. Articles should be in Microsoft Word document format and prepared in the simplest form possible. Pages should be numbered consecutively, beginning with the title page.

All articles submitted to E-Da Med J must include the following information.

Title Page. The title page should be the first page of the manuscript and should include titles, names and affiliations of the authors, an address for correspondence and reprints, and a telephone or fax number as well as an email address. The title page should include a running title of not more than 40 characters not including spaces.

Abstract and Key Words. The abstract should be typed, double-spaced, in 12-point Times New Roman font and may include up to five key words for subject indexing.

Text. Text should be typed double-spaced on A4 (29.7 × 21 cm) paper, with outer margins of 2.5 cm. Each section should begin on a new page. Subheadings are required for descriptions in the methods and results sections to guide the readers’ attention to different aspects of methodology and findings, respectively (e.g., “Study design and protocol”, “Participants”, “Parameters and definitions”, and “Statistical analysis”).

Author Contributions. For research articles with several authors, a short paragraph specifying their individual contributions must be provided. The following statements should be used: “Study Design, X.X. and Y.Y.; Data Collection, X.X.; Statistical Analysis, X.X.; Data Interpretation, X.X., Y.Y. and Z.Z.; Manuscript Preparation, X.X.; Literature Search, X.X.; Funding Acquisition, Y.Y.”, where X.X., Y.Y. are the authors’ names and surnames. “All authors have read and agreed to the published version of the manuscript”. Authorship must be limited to those who have contributed substantially to the work reported.

Funding. Please add: “This research received no external funding” or “This research was funded by NAME OF FUNDER, grant number XXX”.

Institutional Review Board Statement. In this section, you should add the Institutional Review Board Statement and approval number, if relevant to your study. You might choose to exclude this statement if the study did not require ethical approval. Please note that the Editorial Office might ask you for further information. Please add “The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) of NAME OF INSTITUTE (protocol code XXX and date of approval).” for studies involving humans, OR “The animal study protocol was approved by the Institutional Review Board (or Ethics Committee) of NAME OF INSTITUTE (protocol code XXX and date of approval).” for studies involving animals, OR “Ethical review and approval were waived for this study due to XXX (please provide a detailed justification)”, OR “Not applicable” for studies not involving humans or animals.

Informed Consent Statement. Any research article describing a study involving humans should contain this statement. Please add “Informed consent was obtained from all subjects involved in the study.” OR “Patient consent was waived due to XXX (please provide a detailed justification).” OR “Not applicable.” for studies not involving humans. Written informed consent for publication must be obtained from participating patients who can be identified (including by the patients themselves). Please state “Written informed consent has been obtained from the patient(s) to publish this paper”, if applicable.

Data Availability Statement. In this section, please provide details regarding where data supporting reported results can be found, including links to publicly archived datasets analyzed or generated during the study. If the study did not report any data, you might add “Not applicable” here.

Acknowledgements (if any). In this section, you can acknowledge any support given which is not covered by the author contribution or funding sections. This may include administrative and technical support, or donations in kind (e.g., materials used for experiments).

Conflicts of Interest. Declare conflicts of interest or state “The authors declare no conflict of interest.”

References. References should be double-spaced and should be cited in the order of their appearance in the text. Journal references should include the authors, title, journal name, year, volume number, page numbers (first to last), and DOI. Journal references having more than three authors should list only the first three authors followed by the notation "et al". References to books should include authors, chapter title, names of editors, book title, city of publication, publisher, and year of publication. Volume numbers, edition numbers, and specific page numbers should be included when appropriate. If citing a website, provide the author information, article title, website address, and the date of access.

Meanwhile, references should be cited by number (superscript) within the text. If the reference article cited is in a language which does not use the Roman alphabet, it should be translated into English with the original language being indicated in parentheses following the citation of the reference. If previously translated, the translated article may be cited. The abbreviation of a journal title should be consistent with that in the MEDLINE. The EndNote format of E-Da Med J is available on the website of the Journal.

Tables & Figures. Tables should supplement, not duplicate, the text. Abbreviations used in the table must be defined and included as footnotes in alphabetical order.

Figures must be submitted as separate picture files (e.g. TIFF or JPEG) at the correct resolution of a minimum of 600 dpi with an image width of at least 9 cm. Legends should not be included in the figures and should be the last section of the manuscript. All symbols and abbreviations should be defined in the figure legends in alphabetical order.

MANUSCRIPT CHECKLIST

English usage is appropriate.
The title page contains the title, names, and affiliations of all authors, the corresponding author’s address, telephone and fax numbers as well as e-mail address, and a running title of not more than 40 characters (not including spaces).
An abstract of no more than 250 words that conforms to the required format.
All references are accurate and complete.
Each table and figure should include a caption. Figure legends are typed on a separate page.
There are no more than six authors in a case report.
The manuscript is original. Its contents have not been copyrighted or published, and are not being considered for publication, in any language and in any form.
The number of reference should be no more than 100 for a meta-analysis, 30 for an original article, 10 for a case report, and five for images and brief communications.

Keyboarding of Manuscripts

Please prepare your manuscript in doc. or docx. format using Times New Roman font (MS Office Word, size 12).
All considerations regarding typesetting, including page layout and artwork, will be handled by the publisher after receipt of the electronic manuscript. There is no need for the author to input special typesetting codes.
All questions regarding the instructions for authors should be directed to the editorial assistant: Tel: 886-7-6150011 ext. 1614, E-mail: Email住址會使用灌水程式保護機制。你需要啟動Javascript才能觀看它

E-Da MEDICAL JOURNAL Transfer of Copyright Agreement

The undersigned authors have submitted a manuscript entitled:

for publication in the of E-Da Medical Journal (E-Da Med J). By signing this form, all authors agree on the submission and transfer of the copyright of the above-mentioned work to the E-Da Med J without compensation. The copyright refers to the right to publish the work or the materials contained within in any languages, formats, and media as well as to license others to do so during the full term of copyright documented in the copyright law of the Republic of China.

The undersigned authors guarantee that the Work is original, that it is submitted only to E-Da Med J, and that no part of it has been published before in any form and in any language.

(This agreement must be signed by all authors. A photocopy of this form may be used if there are more than six authors.)

Printed Name：______________　Date：_____/_____/_____ (yyyy/mm/dd)　Signature：______________